Early Trials For Coronavirus Vaccine Show "Promise" Unlisted Video
3 years ago
503
News
Moderna
National Institutes
Infection
The New England Journal Of Medicine
H 5 N 1 Clinical Trials
Ebola Vaccine
Drugs
United States
A COVID-19 vaccine has been found to induce immune responses in some volunteers.
The vaccine was developed by Moderna and the National Institutes of Health reports CNN.
Immune responses were detected in all of the volunteers who received it in a Phase 1 study.
These early results showed that the vaccine worked to trigger an immune response with mild side effects.
The side effects include fatigue, chills, headache, muscle pain, pain at the injection site.
This is now the first US vaccine candidate to publish results in a peer-reviewed medical journal.
The vaccine is expected to begin later this month a large Phase 3 trial.
Loading comments...
-
0:30
KTNV
3 years agoCoronavirus vaccine nears final trials
541 -
1:03
Digital Trends
3 years agoRussia has approved a coronavirus vaccine without clinical trials.
542 -
0:29
Newsy
3 years agoNovavax's Potential Coronavirus Vaccine Moves To Phase 2 Trials
584 -
1:53
BPR
3 years agoTrump predicts coronavirus vaccine as early as December
2.53K1 -
2:09
KGTV
3 years agoABC 10News exclusive: San Diego clinic to begin trials of coronavirus vaccine
30 -
3:20
KGTV
3 years agoCoronavirus vaccine development
410 -
0:18
KTNV
3 years agoMexico hosting COVID-19 vaccine trials
405 -
2:01
WPTV
3 years agoWest Palm Beach doctor starting coronavirus vaccine trials in September
63 -
0:24
KTNV
3 years agoCoronavirus vaccine shows 'promising' results
146 -
1:13
Newsy
3 years agoCOVID-19 Vaccine Trials Shows Promise
1.44K1